Related Experiment Video
Updated: Aug 13, 2026
14:23
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
[The quest for an HIV vaccine]
Bulletin De L'Academie Nationale De Medecine
|January 26, 2006
Summary
Despite extensive research and numerous trials for HIV/AIDS vaccines, a broadly protective vaccine remains elusive. Current T cell-stimulating vaccines show promise in controlling viral load and disease progression, but not in preventing infection.
Area of Science:
- Vaccinology
- Immunology
- Virology
Context:
- Over 49 Phase I, 2 Phase II, and 2 Phase III HIV/AIDS vaccine trials involving 12,000+ volunteers and 35+ formulations have been completed since the 1980s.
- Despite identifying neutralizing epitopes, an HIV envelope-based vaccine eliciting broadly reactive neutralizing antibodies has not been achieved.
- A gp120-based vaccine demonstrated no protective efficacy in Phase III trials.
Purpose:
- To review the progress and challenges in developing effective HIV/AIDS vaccines.
- To explore the potential of T cell-stimulating vaccines based on observations in the monkey model.
- To assess the efficacy of various vaccine candidates, including live virus vectors, DNA, and peptides.
Summary:
- Candidate vaccines, including live recombinant canarypox virus (ALVAC), adenovirus type 5 (Ad5), and modified vaccinia virus Ankara (MVA) vectors, are in clinical or preclinical development.
- While no vaccine tested in nonhuman primates has prevented infection, they have controlled viral load and prevented CD4 cell loss.
- T cell-stimulating vaccines aim to control virus replication and slow disease progression rather than prevent initial infection.
Impact:
- Current T cell-stimulating vaccine strategies show potential for managing HIV/AIDS by controlling disease progression.
- The efficacy of these T cell-stimulating vaccines in preventing HIV infection or disease progression in humans requires further determination.
- Continued research into novel vaccine designs and immunogens is crucial for advancing HIV/AIDS prevention and treatment.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...